On the other hand, transient opening of the BBB can be achieved by focused ultrasound treatment, which was shown to result in the reduction of amyloid burden in AD models and enhanced the protective effect of a tau-specific antibody in vivo recently [172–175]. The gene discussed is MAPT; the disease is amyloidosis.